Cargando…

An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept

Aim: The primary goal of this study was to evaluate the reduction in non-perfusion area and improvement in blood flow as well as the reduction in retinal edema on optical coherence tomography angiography (OCT-A) in patients with retinal vein occlusion treated with 2 mg intravitreal injections of afl...

Descripción completa

Detalles Bibliográficos
Autores principales: Śpiewak, Dorota, Witek, Katarzyna, Drzyzga, Łukasz, Mrukwa-Kominek, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572925/
https://www.ncbi.nlm.nih.gov/pubmed/37835843
http://dx.doi.org/10.3390/diagnostics13193100
_version_ 1785120346295238656
author Śpiewak, Dorota
Witek, Katarzyna
Drzyzga, Łukasz
Mrukwa-Kominek, Ewa
author_facet Śpiewak, Dorota
Witek, Katarzyna
Drzyzga, Łukasz
Mrukwa-Kominek, Ewa
author_sort Śpiewak, Dorota
collection PubMed
description Aim: The primary goal of this study was to evaluate the reduction in non-perfusion area and improvement in blood flow as well as the reduction in retinal edema on optical coherence tomography angiography (OCT-A) in patients with retinal vein occlusion treated with 2 mg intravitreal injections of aflibercept. Material and methods: Fifty eyes of nine patients with central retinal vein occlusion (CRVO) and sixteen patients with branch retinal vein occlusion (BRVO), aged 50 to 75 years, were collectively analyzed as retinal vein occlusion (RVO). The following parameters were analyzed: superficial vessel density (VDSF), deep vessel density (VDD), flow area in the outer retina (FAOR), choriocapillaris flow area (FACC), non-flow area (NFA) and the foveal avascular zone (FAZ). Results: OCT-A revealed a reduction in macular edema. The most significant change in central retinal thickness (CRT) was observed between measurement timepoint “5” and the baseline (46%). The non-flow area was also reduced. Following a significant decrease in superficial vessel density 30 days after the first dose of aflibercept, a non-significant increase was noted at the subsequent timepoints. An increase was also found in deep vessel density and choriocapillaris flow area. Improvements in the above OCT-A parameters resulted in increased retinal blood flow and improved visual acuity. Conclusions: Patients with retinal vein occlusion treated with 2 mg aflibercept exhibited reduced macular edema and FAZ, increased vessel density, improved blood flow, and better visual acuity.
format Online
Article
Text
id pubmed-10572925
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105729252023-10-14 An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept Śpiewak, Dorota Witek, Katarzyna Drzyzga, Łukasz Mrukwa-Kominek, Ewa Diagnostics (Basel) Article Aim: The primary goal of this study was to evaluate the reduction in non-perfusion area and improvement in blood flow as well as the reduction in retinal edema on optical coherence tomography angiography (OCT-A) in patients with retinal vein occlusion treated with 2 mg intravitreal injections of aflibercept. Material and methods: Fifty eyes of nine patients with central retinal vein occlusion (CRVO) and sixteen patients with branch retinal vein occlusion (BRVO), aged 50 to 75 years, were collectively analyzed as retinal vein occlusion (RVO). The following parameters were analyzed: superficial vessel density (VDSF), deep vessel density (VDD), flow area in the outer retina (FAOR), choriocapillaris flow area (FACC), non-flow area (NFA) and the foveal avascular zone (FAZ). Results: OCT-A revealed a reduction in macular edema. The most significant change in central retinal thickness (CRT) was observed between measurement timepoint “5” and the baseline (46%). The non-flow area was also reduced. Following a significant decrease in superficial vessel density 30 days after the first dose of aflibercept, a non-significant increase was noted at the subsequent timepoints. An increase was also found in deep vessel density and choriocapillaris flow area. Improvements in the above OCT-A parameters resulted in increased retinal blood flow and improved visual acuity. Conclusions: Patients with retinal vein occlusion treated with 2 mg aflibercept exhibited reduced macular edema and FAZ, increased vessel density, improved blood flow, and better visual acuity. MDPI 2023-09-29 /pmc/articles/PMC10572925/ /pubmed/37835843 http://dx.doi.org/10.3390/diagnostics13193100 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Śpiewak, Dorota
Witek, Katarzyna
Drzyzga, Łukasz
Mrukwa-Kominek, Ewa
An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept
title An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept
title_full An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept
title_fullStr An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept
title_full_unstemmed An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept
title_short An Analysis of Optical Coherence Tomography Angiography (OCT-A) Perfusion Density Maps in Patients Treated for Retinal Vein Occlusion with Intravitreal Aflibercept
title_sort analysis of optical coherence tomography angiography (oct-a) perfusion density maps in patients treated for retinal vein occlusion with intravitreal aflibercept
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572925/
https://www.ncbi.nlm.nih.gov/pubmed/37835843
http://dx.doi.org/10.3390/diagnostics13193100
work_keys_str_mv AT spiewakdorota ananalysisofopticalcoherencetomographyangiographyoctaperfusiondensitymapsinpatientstreatedforretinalveinocclusionwithintravitrealaflibercept
AT witekkatarzyna ananalysisofopticalcoherencetomographyangiographyoctaperfusiondensitymapsinpatientstreatedforretinalveinocclusionwithintravitrealaflibercept
AT drzyzgałukasz ananalysisofopticalcoherencetomographyangiographyoctaperfusiondensitymapsinpatientstreatedforretinalveinocclusionwithintravitrealaflibercept
AT mrukwakominekewa ananalysisofopticalcoherencetomographyangiographyoctaperfusiondensitymapsinpatientstreatedforretinalveinocclusionwithintravitrealaflibercept
AT spiewakdorota analysisofopticalcoherencetomographyangiographyoctaperfusiondensitymapsinpatientstreatedforretinalveinocclusionwithintravitrealaflibercept
AT witekkatarzyna analysisofopticalcoherencetomographyangiographyoctaperfusiondensitymapsinpatientstreatedforretinalveinocclusionwithintravitrealaflibercept
AT drzyzgałukasz analysisofopticalcoherencetomographyangiographyoctaperfusiondensitymapsinpatientstreatedforretinalveinocclusionwithintravitrealaflibercept
AT mrukwakominekewa analysisofopticalcoherencetomographyangiographyoctaperfusiondensitymapsinpatientstreatedforretinalveinocclusionwithintravitrealaflibercept